LncRNA TUG1 promotes hepatic lipid accumulation by targeting the miR-29a-3p/SREBP-2/HMGCR axis in MAFLD

Key Points

• Lipid accumulation increases significantly in the presence of TUG1, targeting the miR-29a-3p pathway.
• Key evidence shows that modulation of the SREBP-2 and HMGCR pathways associates with higher lipid levels.
• Study employs observational analysis to understand the relationship between lncRNA TUG1 and hepatic lipid metabolism.
• Highlights the potential for TUG1 as a therapeutic target to mitigate MAFLD effects, indicating necessary follow-up research.